AFJKU Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)-61.5% YoY
Profit margin0.0%FINANCIAL SERVICES
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
0.0%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
0.23
Last earnings
Mar 31, 2026 · Reported $0.01
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 2 · 21 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Aimei Health Technology Co., Ltd Unit

Aimei Health Technology Co., Ltd. is a leading innovator in the healthcare sector, dedicated to improving patient care via advanced technology and innovative health solutions. Specializing in the development and production of state-of-the-art medical devices and integrated health management systems, the company focuses on enhancing patient outcomes and optimizing healthcare delivery. With a strong commitment to research and development, strategic partnerships, and a proactive approach to market dynamics, Aimei is well-positioned for long-term growth in the evolving global healthcare landscape.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
10 EAST 53RD STREET, NEW YORK, NY
Fiscal year end
December
Latest quarter
Mar 31, 2026
Shares outstanding$0
52W high$78.00
52W low$7.60

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer